Amit Oza, MD
Princess Margaret Cancer Centre, UHN and Mt. Sinai Health System · Princess Margaret Cancer Centre · University Health Network, Toronto
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Amit Oza, MD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 05:30 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT04239014 · A Study to Evaluate the Effectiveness and Tolerability of a Second Maintenance Treatment in Participants With Ovarian Cancer, Who Have Previously Received Polyadenosine 5'Diphosphoribose [Poly (ADP Ribose)] Polymerase Inhibitor (PARPi) Treatment.AstraZeneca · withdrawn · Ovarian Cancer · principal investigator
- Ph2/Ph3NCT04159155 · A Study of Various Treatments in Serous or p53 Abnormal Endometrial CancerUniversity Health Network, Toronto · terminated · Endometrial Carcinoma, P53 Mutation, Serous Carcinoma · principal investigator
- N/ANCT02334761 · Biopsies in Oncology - Prospective Study of Impact on Patient's Quality of Life.University Health Network, Toronto · completed · Pathology · principal investigator
- Ph1NCT02185690 · A Phase I/Ib Study of MEK162, a MEK Inhibitor, in Combination With Carboplatin and Pemetrexed in Patients With Non-squamous Carcinoma of the LungUniversity Health Network, Toronto · completed · Lungcancer · study director
- Ph2NCT01081951 · Study to Compare the Efficacy and Safety of Olaparib When Given in Combination With Carboplatin and Paclitaxel, Compared With Carboplatin and Paclitaxel in Patients With Advanced Ovarian CancerAstraZeneca · active not recruiting · Ovarian Cancer · principal investigator
- Ph2NCT00607607 · A Phase 2 Study of Oral MKC-1 in Patients With Ovarian or Endometrial CancerCASI pharmaceuticals, Inc. · completed · Ovarian Cancer, Endometrial Cancer · principal investigator
- Ph1/Ph2NCT00510250 · A Phase I/II Study of Cisplatin and Radiation in Combination With Sorafenib in Cervical CancerUniversity Health Network, Toronto · completed · Cancer of the Cervix · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 05:30 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 10 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
PubMed returned no clinical-trial papers for this author name.